0001474506-23-000054.txt : 20230206 0001474506-23-000054.hdr.sgml : 20230206 20230206160134 ACCESSION NUMBER: 0001474506-23-000054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230203 FILED AS OF DATE: 20230206 DATE AS OF CHANGE: 20230206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ashman Philip CENTRAL INDEX KEY: 0001564990 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34703 FILM NUMBER: 23590638 MAIL ADDRESS: STREET 1: 6120 WINDWARD PARKWAY, SUITE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALIMERA SCIENCES INC CENTRAL INDEX KEY: 0001267602 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200028718 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-990-5740 MAIL ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2023-02-03 0 0001267602 ALIMERA SCIENCES INC ALIM 0001564990 Ashman Philip 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 0 1 0 0 Chief Operating Officer & SVP Common Stock 2023-02-03 4 F 0 2889 2.8104 D 30315 D Represents shares of the Issuer's restricted common stock sold to satisfy tax obligations relating to the vesting of shares of the Issuer's restricted common stock previously awarded to the Reporting Person. Such sale was executed pursuant to the mandatory terms of the Issuer's restricted stock award agreement that are intended to permit such sale to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to comply with the requirements of Rule 10b5-1(c). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.81 to $2.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Philip Ashman 2023-02-06